Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-16 Sale | 2023-06-21 5:54 pm | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $54.67 | $1,421,529 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-08 Option Award | 2024-06-11 5:25 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:23 pm | N/A 2034-06-06 | OptiNose Inc. | OPTN | Heyman Tomas J. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 8:20 pm | N/A N/A | EXELIXIS INC. | EXEL | Heyman Tomas J. Director | 18,838 | $0 | 37,014 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:52 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:54 pm | N/A 2030-06-09 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $0 | 0 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:54 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $25.04 | 0 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 4:30 pm | N/A 2033-06-11 | Xilio Therapeutics Inc. | XLO | Heyman Tomas J. Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 2:03 pm | N/A 2033-06-08 | OptiNose Inc. | OPTN | Heyman Tomas J. Director | 53,500 | $0 | 53,500 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 9:51 pm | 2023-05-31 2030-05-30 | EXELIXIS INC. | EXEL | Heyman Tomas J. Director | 54,529 | $0 | 54,529 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 6:46 pm | N/A 2033-05-22 | Invivyd Inc. | IVVD | Heyman Tomas J. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-15 Option Award | 2022-09-16 4:15 pm | N/A 2032-09-14 | Xilio Therapeutics Inc. | XLO | Heyman Tomas J. Director | 26,400 | $0 | 26,400 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:31 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | Heyman Tomas J. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 10:24 am | N/A 2032-06-08 | OptiNose Inc. | OPTN | Heyman Tomas J. Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2021-08-05 9:22 pm | N/A 2031-06-29 | Adagio Therapeutics Inc. | ADGI | Heyman Tomas J. Director | 0 | $0 | 125,380 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-10 3:15 pm | N/A 2031-06-09 | OptiNose Inc. | OPTN | Heyman Tomas J. Director | 14,439 | $0 | 14,439 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:59 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-04 5:17 pm | N/A 2030-12-01 | OptiNose Inc. | OPTN | Heyman Tomas J. Director | 28,879 | $0 | 28,879 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 7:01 pm | N/A 2030-06-09 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $0 | 26,000 (Direct) | View |